Spondyloarthritis (SpA) is a chronic systemic rheumatic disease, the hallmark manifestation of which is inflammatory back pain, and may also involve…

Interstitial lung disease (ILD) is a common pulmonary manifestation of rheumatoid arthritis (RA). It has emerged in recent studies as a key prognostic…

A significant proportion of patients with systemic lupus erythematosus develop renal disease, which has a major impact on the course of the disease…

Methotrexate (MTX) is the most commonly used medication to treat RA. MTX pneumonitis (MTX-pneu) is a rare disease entity reported in MTX users.

When discussing the impact of rheumatic disease states with patients living with these conditions, fatigue is often at the forefront of that discussion…

Rheumatoid arthritis (RA) is associated with changes in skeletal health, including increased risk of fracture.

The purpose of this review is to provide a clinically focussed description of the relevant aetiopathogenesis, clinical expression of disease, approach to the assessment and treatment of Systemic Sclerosis, and highlight the recent advances and future challenges associated with this complex disease.

To correlate audiometry with atherosclerosis. Presbycusis is associated  with age and atherosclerosis; a strong correlation might present opportunities to…

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease which predominantly involves the axial skeleton and sacroiliac joints.

TYPE 5 collagen plays a crucial role in regulating scar tissue size in the heart and may explain why certain individuals experience…